In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using (18)F-fluoromisonidazole PET-CT

Carbon dioxide (CO(2)) treatment is reported to have an antitumor effect owing to the improvement in intratumoral hypoxia. Previous studies were based on histological analysis alone. In the present study, the improvement in intratumoral hypoxia by percutaneous CO(2) treatment in vivo was determined...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama, Koji, Okada, Takuya, Ueha, Takeshi, Isohashi, Kayako, Ikeda, Hayato, Kanai, Yasukazu, Sasaki, Koji, Gentsu, Tomoyuki, Ueshima, Eisuke, Sofue, Keitaro, Nogami, Munenobu, Yamaguchi, Masato, Sugimoto, Koji, Sakai, Yoshitada, Hatazawa, Jun, Murakami, Takamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816357/
https://www.ncbi.nlm.nih.gov/pubmed/33574946
http://dx.doi.org/10.3892/ol.2021.12468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816357/
https://www.ncbi.nlm.nih.gov/pubmed/33574946
http://dx.doi.org/10.3892/ol.2021.12468

Ejemplares similares